Literature DB >> 23036241

Pediatric pharmacokinetics: human development and drug disposition.

Ryan S Funk1, Jacob T Brown, Susan M Abdel-Rahman.   

Abstract

Human development is described by the various anatomic and physiologic changes that occur as the single-celled zygote matures into an adult human being. Concomitant with bodily maturation are changes in the complex interactions between pharmacologic agents and the biologic matrix that is the human body. Profound changes in the manner by which drugs traverse the body during development can have significant implications in drug efficacy and toxicity. Although not a replacement for well-conducted, pediatric, pharmacokinetic studies, an understanding of developmental biology and the mechanisms for drug disposition invariably assists the pediatric clinician with the judicious use of medications in children.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23036241     DOI: 10.1016/j.pcl.2012.07.003

Source DB:  PubMed          Journal:  Pediatr Clin North Am        ISSN: 0031-3955            Impact factor:   3.278


  11 in total

1.  Generic drug products in paediatrics: Where are the data?

Authors:  Sílvia M Illamola; Angela K Birnbaum; Catherine M Sherwin
Journal:  Br J Clin Pharmacol       Date:  2019-07-07       Impact factor: 4.335

2.  Challenges and Opportunities in the Development of HIV Medications in Pediatric Patients.

Authors:  Gueorgui Dubrocq; Natella Rakhmanina; B Ryan Phelps
Journal:  Paediatr Drugs       Date:  2017-04       Impact factor: 3.022

Review 3.  What do drug transporters really do?

Authors:  Sanjay K Nigam
Journal:  Nat Rev Drug Discov       Date:  2014-12-05       Impact factor: 84.694

4.  RNA-sequencing quantification of hepatic ontogeny and tissue distribution of mRNAs of phase II enzymes in mice.

Authors:  Hong Lu; Sumedha Gunewardena; Julia Y Cui; Byunggil Yoo; Xiao-bo Zhong; Curtis D Klaassen
Journal:  Drug Metab Dispos       Date:  2013-02-04       Impact factor: 3.922

5.  Larotrectinib for paediatric solid tumours harbouring NTRK gene fusions: phase 1 results from a multicentre, open-label, phase 1/2 study.

Authors:  Theodore W Laetsch; Steven G DuBois; Leo Mascarenhas; Brian Turpin; Noah Federman; Catherine M Albert; Ramamoorthy Nagasubramanian; Jessica L Davis; Erin Rudzinski; Angela M Feraco; Brian B Tuch; Kevin T Ebata; Mark Reynolds; Steven Smith; Scott Cruickshank; Michael C Cox; Alberto S Pappo; Douglas S Hawkins
Journal:  Lancet Oncol       Date:  2018-03-29       Impact factor: 41.316

Review 6.  Exposure Matching for Extrapolation of Efficacy in Pediatric Drug Development.

Authors:  Yeruk Mulugeta; Jeffrey S Barrett; Robert Nelson; Abel Tilahun Eshete; Alvina Mushtaq; Lynne Yao; Nicole Glasgow; Andrew E Mulberg; Daniel Gonzalez; Dionna Green; Jeffry Florian; Kevin Krudys; Shirley Seo; Insook Kim; Dakshina Chilukuri; Gilbert J Burckart
Journal:  J Clin Pharmacol       Date:  2016-11       Impact factor: 3.126

Review 7.  Ethanol pharmacokinetics in neonates and infants.

Authors:  Elizabeth Marek; Walter K Kraft
Journal:  Curr Ther Res Clin Exp       Date:  2014-10-22

Review 8.  Effect of Kidney Function on Drug Kinetics and Dosing in Neonates, Infants, and Children.

Authors:  Frederique Rodieux; Melanie Wilbaux; Johannes N van den Anker; Marc Pfister
Journal:  Clin Pharmacokinet       Date:  2015-12       Impact factor: 6.447

Review 9.  Antipsychotics in children and adolescents with schizophrenia: a systematic review and meta-analysis.

Authors:  Siddharth Sarkar; Sandeep Grover
Journal:  Indian J Pharmacol       Date:  2013 Sep-Oct       Impact factor: 1.200

10.  Population Pharmacokinetics of Pyronaridine in Pediatric Malaria Patients.

Authors:  Amal Ayyoub; Janthima Methaneethorn; Michael Ramharter; Abdoulaye A Djimde; Mamadou Tekete; Stephan Duparc; Isabelle Borghini-Fuhrer; Jang-Sik Shin; Lawrence Fleckenstein
Journal:  Antimicrob Agents Chemother       Date:  2015-12-14       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.